全文获取类型
收费全文 | 79145篇 |
免费 | 6017篇 |
国内免费 | 255篇 |
专业分类
耳鼻咽喉 | 907篇 |
儿科学 | 2043篇 |
妇产科学 | 1085篇 |
基础医学 | 10741篇 |
口腔科学 | 843篇 |
临床医学 | 8383篇 |
内科学 | 17007篇 |
皮肤病学 | 884篇 |
神经病学 | 7735篇 |
特种医学 | 3058篇 |
外科学 | 12801篇 |
综合类 | 886篇 |
一般理论 | 92篇 |
预防医学 | 5924篇 |
眼科学 | 1960篇 |
药学 | 5365篇 |
中国医学 | 94篇 |
肿瘤学 | 5609篇 |
出版年
2023年 | 607篇 |
2022年 | 888篇 |
2021年 | 2411篇 |
2020年 | 1358篇 |
2019年 | 2206篇 |
2018年 | 2527篇 |
2017年 | 1801篇 |
2016年 | 1894篇 |
2015年 | 2214篇 |
2014年 | 3210篇 |
2013年 | 4060篇 |
2012年 | 6511篇 |
2011年 | 6750篇 |
2010年 | 3691篇 |
2009年 | 3235篇 |
2008年 | 5393篇 |
2007年 | 5590篇 |
2006年 | 5179篇 |
2005年 | 5136篇 |
2004年 | 4634篇 |
2003年 | 4255篇 |
2002年 | 3857篇 |
2001年 | 598篇 |
2000年 | 396篇 |
1999年 | 566篇 |
1998年 | 786篇 |
1997年 | 588篇 |
1996年 | 477篇 |
1995年 | 426篇 |
1994年 | 400篇 |
1993年 | 395篇 |
1992年 | 250篇 |
1991年 | 198篇 |
1990年 | 180篇 |
1989年 | 162篇 |
1988年 | 156篇 |
1987年 | 130篇 |
1986年 | 132篇 |
1985年 | 146篇 |
1984年 | 181篇 |
1983年 | 150篇 |
1982年 | 236篇 |
1981年 | 232篇 |
1980年 | 165篇 |
1979年 | 95篇 |
1978年 | 114篇 |
1977年 | 100篇 |
1976年 | 70篇 |
1975年 | 59篇 |
1974年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
181.
Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. 总被引:7,自引:0,他引:7
Kazunori Inabe Masamichi Ishiai Andrew M Scharenberg Norman Freshney Julian Downward Tomohiro Kurosaki 《The Journal of experimental medicine》2002,195(2):189-200
To elucidate the mechanism(s) by which Vav3, a new member of the Vav family proteins, participates in B cell antigen receptor (BCR) signaling, we have generated a B cell line deficient in Vav3. Here we report that Vav3 influences phosphoinositide 3-kinase (PI3K) function through Rac1 in that phosphatidylinositol-3,4,5-trisphosphate (PIP3) generation was attenuated by loss of Vav3 or by expression of a dominant negative form of Rac1. The functional interaction between PI3K and Rac1 was also demonstrated by increased PI3K activity in the presence of GTP-bound Rac1. In addition, we show that defects of calcium mobilization and c-Jun NH2-terminal kinase (JNK) activation in Vav3-deficient cells are relieved by deletion of a PIP3 hydrolyzing enzyme, SH2 domain-containing inositol polyphosphate 5'-phosphatase (SHIP). Hence, our results suggest a role for Vav3 in regulating the B cell responses by promoting the sustained production of PIP3 and thereby calcium flux. 相似文献
182.
OBJECTIVE: To assess the use of infiltration with local anaesthetics levobupivacaine and bupivacaine, during inguinal hernia repair. DESIGN: Double-blind, randomised study. SETTING: Postgraduate medical school, United Kingdom. SUBJECTS: 69 male patients aged 18 years or older. INTERVENTIONS: Wound infiltration with 0.25% levobupivacaine and 0.25% racemic bupivacaine. MAIN OUTCOME MEASURES: Area under the curve (AUC) of visual analogue scale (VAS) scores for postoperative pain at rest in the supine position, rising from the supine to the sitting position, and walking, against time for both treatment groups. RESULTS: There were no significant differences between treatment groups for the AUC of VAS scores for postoperative pain, global verbal pain rating or time to first dose of analgesic medication. CONCLUSIONS: Levobupivacaine exerts a similar anaesthetic and analgesic effect to racemic bupivacaine when infiltrated both intraoperatively and during the early postoperative period for elective inguinal hernia repair. 相似文献
183.
184.
Christian J Streck Paxton V Dickson Catherine Y C Ng Junfang Zhou John T Gray Amit C Nathwani Andrew M Davidoff 《Clinical cancer research》2005,11(16):6020-6029
PURPOSE: Type I IFNs (IFN-alpha/beta) have shown significant antitumor activity in preclinical models but limited efficacy and significant toxicity in clinical trials. We hypothesized that the antitumor activity of type I IFNs could be enhanced by chronic, low-dose systemic delivery and sought to test this in murine neuroblastoma models. EXPERIMENTAL DESIGN: Continuous liver-generated expression of human IFN-beta (hINF-beta) was achieved through a gene therapy-mediated approach using adeno-associated virus vectors encoding hIFN-beta (AAV hINF-beta). Orthotopic localized retroperitoneal and disseminated models of neuroblastoma were established using three different xenografts. Immunohistochemical analysis and ELISA were used to evaluate the antiangiogenic effect of therapy. RESULTS: The development of both localized orthotopic (retroperitoneal) and disseminated neuroblastoma was prevented in all mice expressing hINF-beta. Continued growth of established retroperitoneal tumors, treated with AAV hINF-beta as monotherapy, was significantly restricted, and survival for mice with established, disseminated disease was significantly prolonged following administration of AAV hINF-beta. Analysis of treated tumors revealed a significant antiangiogenic effect. Mean intratumoral vessel density was diminished and expression of the angiogenic factors vascular endothelial growth factor and basic fibroblast growth factor were both decreased. Finally, combination therapy in which AAV hIFN-beta was used together with low-dose cyclophosphamide resulted in regression of both established retroperitoneal and disseminated disease. CONCLUSIONS: AAV-mediated delivery of hIFN-beta when used as monotherapy was able to restrict neuroblastoma growth due in part to inhibition of angiogenesis. When used in combination with conventional chemotherapy, AAV hIFN-beta was able to effect complete tumor regression. 相似文献
185.
Gertie J. Oostingh Hugh F. S. Davies Kerrie C. G. Tang J. Andrew Bradley Craig J. Taylor 《American journal of transplantation》2002,2(3):267-273
We have previously shown that IgG HLA specific antibodies in the sera of highly sensitised patients awaiting renal transplantation can cross-react with swine leukocyte antigens (SLA). In this study we determined the frequency of patient serum IgG HLA specific antibody binding to a porcine lymphocyte panel and the likelihood of locating a cross-match negative pig donor for sensitised patients. Serum samples (n = 82) were obtained from 35 sensitised [current IgG panel reactive antibodies (PRA) > 10%] and seven nonsensitised patients awaiting renal transplantation at Addenbrooke's Hospital, Cambridge, UK. Fifty sera had IgG HLA specific PRA of 11-84%, 20 had IgG PRA of >84% and 12 had 0% PRA (negative controls). Sera were absorbed with porcine erythrocytes to remove xenoreactive natural antibodies and tested for cross-reactive IgG HLA specific antibody binding by flow cytometry against a panel of porcine lymphocytes obtained from 23 human decay accelerating factor (hDAF) transgenic pigs. A total of 1,884 cross-match combinations were tested and 369 (20%) gave a positive porcine lymphocyte cross-match. For sera from sensitised patients with IgG PRA (11-64%), only 6 of 805 (0.75%) cross-match tests were positive. In contrast, for sera from patients with high IgG PRA (>64%), 363 of 805 (45%) cross-match tests were positive (p < 0.0001). There was no difference in the frequency of positive cross-matches between patient sera with IgG PRA 65-84% and highly sensitised patient sera with IgG PRA 85-100% [156/345 (45%) vs. 207/460 (45%)]. This study demonstrates that only patient sera with broadly reactive IgG HLA specific PRA (>64%) cross-react with porcine lymphocytes. If future clinical trials of xenotransplantation are undertaken, it may be of value to select a cross-match-negative pig organ donor for such patients. 相似文献
186.
187.
188.
Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. 总被引:1,自引:0,他引:1
Jonathan M Schott Jessica E Simon Nick C Fox Andrew P King M Nadeem Khan Lisa Cipolotti Dominic C Paviour John M Stevens Martin N Rossor 《Movement disorders》2003,18(8):955-958
We describe the pattern and progression of atrophy delineated using fluid registration of serial magnetic resonance imaging scans in a case of multiple system atrophy (MSA). The in vivo findings were consistent with those found at postmortem, including significant supratentorial atrophy concurrent with an unusual degree of cognitive impairment for MSA. 相似文献
189.
Dennis M Mello MD Doff B McElhinney MS Andrew J Parry MD Norman H Silverman MD Frank L Hanley MD 《The Annals of thoracic surgery》1997,64(6):1808-1810
In hearts with a common arterial trunk (truncus arteriosus), there is almost always an inverse development of the aortic arch and the ductus arteriosus. Truncus with a normal aortic arch and a patent ductus is a rare echocardiographic and surgical finding. In this report, we describe 2 neonates in whom truncus arteriosus with a normal aortic arch and a medium or large patent ductus was diagnosed by preoperative echocardiography (without catheterization) and confirmed intraoperatively. 相似文献
190.
A primary cardiac osteogenic sarcoma is described in a patient presenting with a left atrial obstructive lesion. Wide surgical excision was possible with left atrial reconstruction and mitral valve replacement. The patient survived the operation and was symptom free for 1 year, finally dying at 18 months of cerebral metastases. 相似文献